On January 22, 2018, Petra Pharma Corporation closed the transaction. The company has received $31,204,516 in funding in the transaction from 16 investors. The company received $10,000,005 as part of the third tranche.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 USD | -2.12% | +0.27% | -12.68% |
14/05 | Transcript : 180 Degree Capital Corp., Q1 2024 Earnings Call, May 14, 2024 | |
15/04 | Transcript : 180 Degree Capital Corp. - Shareholder/Analyst Call |
1st Jan change | Capi. | |
---|---|---|
-12.68% | 3.58Cr | |
+27.89% | 340.95Cr | |
+12.82% | 176.95Cr | |
+12.81% | 159.84Cr | |
-11.54% | 125.46Cr | |
+31.12% | 89Cr | |
+9.99% | 67Cr | |
+52.79% | 64Cr | |
-4.17% | 52Cr | |
+40.37% | 51Cr |
- Stock Market
- Equities
- TURN Stock
- News 180 Degree Capital Corp.
- Petra Pharma Corporation announced that it has received $31.204516 million in funding from a group of investors